.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
McKinsey
US Department of Justice
Federal Trade Commission
Medtronic
Cipla
Chinese Patent Office
Harvard Business School
Argus Health
Chubb

Generated: September 25, 2017

DrugPatentWatch Database Preview

Silarx Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for SILARX PHARMS INC, and what generic and branded alternatives to SILARX PHARMS INC drugs are available?

SILARX PHARMS INC has ten approved drugs.



Summary for Applicant: Silarx Pharms Inc

Patents:0
Tradenames:9
Ingredients:9
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Silarx Pharms Inc
RISPERIDONE
risperidone
SOLUTION;ORAL202386-001Jan 12, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL207236-002Nov 10, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
SYRUP;ORAL201674-001Aug 21, 2013AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
SOLUTION;ORAL204033-001Oct 13, 2015AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
CYPROHEPTADINE HYDROCHLORIDE
cyproheptadine hydrochloride
SYRUP;ORAL203191-001Jul 13, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
LEVOCETIRIZINE DIHYDROCHLORIDE
levocetirizine dihydrochloride
SOLUTION;ORAL204599-001May 15, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
ARIPIPRAZOLE
aripiprazole
SOLUTION;ORAL204171-001Aug 14, 2015AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
LAMIVUDINE
lamivudine
SOLUTION;ORAL203564-001Oct 31, 2014AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
LOPINAVIR AND RITONAVIR
lopinavir; ritonavir
SOLUTION;ORAL207407-001Dec 27, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Silarx Pharms Inc
ESCITALOPRAM OXALATE
escitalopram oxalate
SOLUTION;ORAL090477-001Jun 12, 2013AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Cerilliant
Fish and Richardson
Chubb
Argus Health
Queensland Health
Harvard Business School
Accenture
QuintilesIMS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot